Saturating at 95% on three liters nasal cannula.
The patient was made NPO and then initially started on TPN via PICC line that was placed [**2157-2-14**].
G-tube was changed [**2-15**] and patient was slowed started on J-tube feeding at one-half strength starting at 20 cc/hr and slowly increased to a goal rate of 100 cc.
The week before surgery the patient underwent abdominal chest wall preparation with Hibiclens everyday and was optimized for Operating Room on [**2157-4-26**].
The first part was exploratory laparotomy with removal of [**Doctor Last Name 4726**]-Tex and Marlex mesh, lysis of adhesions, enterectomy, enterostomy and feeding jejunostomy.
During this surgery, 18 inches of small bowel starting three feet distally to the ligament of Treitz were removed because the segment _________ anastomosis of enterocutaneous fistulae.
This first part of the surgery was done by Dr. [**Last Name (STitle) 957**] and the Blue Surgery team.
The second part of the surgery was done by Dr. [**Last Name (STitle) **] and the Plastic Surgery team and the procedures included bilateral muscle flap component separation, abdominal wall reconstruction with left pedicle tensor fascia lata fascia and split thickness skin graft of approximately 440 cm squared.
The patient underwent the two part surgery without any complication and postoperatively was transferred to the Trauma Surgical Intensive Care Unit intubated in stable condition.
The patient was restarted on tube feeds at one-half strength of 20 cc and it was advanced in rate.
During his stay in the Surgical Intensive Care Unit the patient received appropriate antibiotics and was transferred to the floor on postoperative day six without any complications.
On postoperative day seven, the patient tolerated clear liquids and was advanced to a regular diet as tolerated with discontinuation of TPN and tube feed cycled only during the night.
By discharge, the surgical wound has granulated beautifully but still requires vacuum dressing change every other day.
in addition to two-thirds strength tube feed at 90 cc/hour overnight.
The patient was put on telemetry and cardiologist consulted.
The patient was started on intravenous Lopressor for rate control and monitored on telemetry.
Postoperatively, the patient had supraventricular tachycardia and Cardiology Service was consulted again and this was controlled with intravenous Lopressor, digoxin and amiodarone.
The patient was diuresed with intravenous Lasix and did well.
Towards the end of his hospital stay, the patient had an episode of bradycardia and this was resolved with discontinuation of amiodarone and decrease in the dose of Lopressor.
The patient was continued on his preadmission medications which included fluticasone 110 mcg two puffs inhaler b.i.d., albuterol nebulizer one treatment q.
and Atrovent nebulizer treatment one treatment q.
as well as albuterol one to two puffs inhaler q.
prednisone 5 mg q. day.
During his prolonged hospital stay, the patient has always had productive sputum and had transmitted sounds on lung examinations.
Genitourinary system:  The patient had Foley catheter in postoperatively to prevent contamination of his skin graft donor site with urine.
The Foley catheter was eventually discontinued with healing skin graft donor site and patient received terazosin q. hs.
The tip of the glans of the penis had a small ulceration with Foley catheter use.
With appropriate skin care provided, the ulceration has improved and Foley catheter was discontinued.
Hematology:  On [**4-11**] to 27th, the patient received two units of packed red blood cells with a decrease in hematocrit.
During his operation on [**4-26**] the patient also received three units of packed red blood cells and three units of fresh frozen plasma.
The patient is currently on iron sulfate 325 mg b.i.d.
Endocrine system:  The patient was covered with regular insulin sliding scale but did not require much dosage.
During his prolonged hospital stay, the patient received steroids, parenteral and p.o.
forms, because of his history of severe chronic obstructive pulmonary disease and currently remains on prednisone 5 mg p.o.
Infectious Disease:  On [**3-3**] patient's Kefzol was changed to penicillin for presumed local cellulitis around the abdominal wound site, however, patient remained afebrile.
On [**3-21**] gentamicin was added to penicillin for persistent cellulitis around the surgical wound site.
Postoperatively, patient was started on gentamicin and levofloxacin.
Vancomycin was added to his gentamicin and levofloxacin when the tissue culture from [**4-26**] came back with Proteus, Pseudomonas and methicillin-resistant Staphylococcus aureus.
Catheter tip culture from [**5-1**] also came back positive for MRSA and patient was continued on vancomycin, levofloxacin and gentamicin.
On [**5-4**] the urine culture grew yeast, more than 100,000 colonies, and patient was started on fluconazole 400 mg.
Levofloxacin, vancomycin, gentamicin and fluconazole are now currently discontinued.
Patient is now only on Keflex 500 mg p.o.
Erythema and induration around the G-tube site was noted and was treated with Neosporin topical antibiotic ointment and Betadine with dressing changes.
Pain management:  The patient was initially managed kept on morphine PCA and was switched over to p.o.
Postoperatively, patient was initially sedated with propofol while in Surgical Intensive Care Unit.
When he was awake, patient was using morphine sulfate PCA.
On discharge to the floor patient received Roxicet 10 cc p.o.
with morphine 2 mg IV q.
During Vac dressing changes, patient was premedicated with morphine 4 mg to 12 mg IV q.o.d.
The patient is currently on Celexa and Paxil.
It was recommended that the patient discontinue Neurontin and mirtazapine and patient was started on quinine sulfate 300 mg p.o.
Enterocutaneous fistulae status post exploratory laparotomy, removal of [**Doctor Last Name 4726**]-Tex and Marlex mesh, lysis of adhesions, enterectomy, enterostomy and feeding jejunostomy, bilateral muscle flap component separation, abdominal wall reconstruction with left pedicle tensor fascia lata and split thickness skin graft.
